These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 38615387)

  • 21. Follow-up after primary treatment of soft tissue sarcoma of extremities: impact of frequency of follow-up imaging on disease-specific survival.
    Chou YS; Liu CY; Chen WM; Chen TH; Chen PC; Wu HT; Chiou HJ; Shiau CY; Wu YC; Liu CL; Chao TC; Tzeng CH; Yen CC
    J Surg Oncol; 2012 Aug; 106(2):155-61. PubMed ID: 22297812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma.
    Patel S; von Mehren M; Reed DR; Kaiser P; Charlson J; Ryan CW; Rushing D; Livingston M; Singh A; Seth R; Forscher C; D'Amato G; Chawla SP; McCarthy S; Wang G; Parekh T; Knoblauch R; Hensley ML; Maki RG; Demetri GD
    Cancer; 2019 Aug; 125(15):2610-2620. PubMed ID: 31173362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retroperitoneal sarcoma: is it time to change the surgical policy?
    Mussi C; Colombo P; Bertuzzi A; Coladonato M; Bagnoli P; Secondino S; Navarria P; Morenghi E; Santoro A; Quagliuolo V
    Ann Surg Oncol; 2011 Aug; 18(8):2136-42. PubMed ID: 21537866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histopathologic type: an independent prognostic factor in primary soft tissue sarcoma of the extremity?
    Koea JB; Leung D; Lewis JJ; Brennan MF
    Ann Surg Oncol; 2003 May; 10(4):432-40. PubMed ID: 12734093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reassessment and clinicopathological prognostic factors of malignant fibrous histiocytoma of soft parts.
    Oda Y; Tamiya S; Oshiro Y; Hachitanda Y; Kinukawa N; Iwamoto Y; Tsuneyoshi M
    Pathol Int; 2002 Sep; 52(9):595-606. PubMed ID: 12406189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic accuracy of percutaneous biopsy in retroperitoneal sarcoma.
    Almond LM; Tirotta F; Tattersall H; Hodson J; Cascella T; Barisella M; Marchianò A; Greco G; Desai A; Ford SJ; Gronchi A; Fiore M; Morosi C
    Br J Surg; 2019 Mar; 106(4):395-403. PubMed ID: 30675910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group.
    MacNeill AJ; Miceli R; Strauss DC; Bonvalot S; Hohenberger P; Van Coevorden F; Rutkowski P; Callegaro D; Hayes AJ; Honoré C; Fairweather M; Cannell A; Jakob J; Haas RL; Szacht M; Fiore M; Casali PG; Pollock RE; Raut CP; Gronchi A; Swallow CJ
    Cancer; 2017 Jun; 123(11):1971-1978. PubMed ID: 28152173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nomograms Predict Cancer-Specific and Overall Survival of Patients With Primary Limb Leiomyosarcoma.
    Wang W; Hong J; Meng J; Wu H; Shi M; Yan S; Huang Y
    J Orthop Res; 2019 Jul; 37(7):1649-1657. PubMed ID: 30977539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival analysis and treatment strategies for limb liposarcoma patients with metastasis at presentation.
    Wang S; Zhou Y; Wang H; Ling J
    Medicine (Baltimore); 2021 Apr; 100(13):e25296. PubMed ID: 33787618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors in retroperitoneal sarcomas: ploidy of DNA as a predictor of clinical outcome.
    Herman K; Gruchała A; Niezabitowski A; Gliński B; Lackowska B
    J Surg Oncol; 1999 May; 71(1):32-5. PubMed ID: 10362089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of chemotherapy on survival in surgically resected retroperitoneal sarcoma.
    Miura JT; Charlson J; Gamblin TC; Eastwood D; Banerjee A; Johnston FM; Turaga KK
    Eur J Surg Oncol; 2015 Oct; 41(10):1386-92. PubMed ID: 26251340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk.
    Dalal KM; Kattan MW; Antonescu CR; Brennan MF; Singer S
    Ann Surg; 2006 Sep; 244(3):381-91. PubMed ID: 16926564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological characteristics and prognostic factors of T1 (≤5 cm) soft tissue sarcoma -- a comparative study with T2 (>5 cm) soft tissue sarcoma.
    Kang S; Han I; Lee S; Kim W; Kim H
    Eur J Surg Oncol; 2014 Apr; 40(4):406-11. PubMed ID: 24388741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Proposed Staging System for Improved Prognostication of MDM2-amplified Liposarcoma.
    Tucci JJ; Dashti NK; Cates JMM
    Am J Surg Pathol; 2021 Jan; 45(1):101-107. PubMed ID: 32796171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retroperitoneal Sarcomas: Does Laterality Matter?
    Lou J; Moten AS; Reddy SS; Howell KJ; Movva S; von Mehren M; Farma JM
    J Surg Res; 2019 Dec; 244():34-41. PubMed ID: 31279261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leiomyosarcoma: investigation of prognostic factors for risk-stratification model.
    Kim HJ; Cho YJ; Kim SH; Rha SY; Ahn JB; Yang WI; Lee YH; Suh JS; Roh JK; Kim KS; Choi YD; Shin KH; Kim HS
    Int J Clin Oncol; 2015 Dec; 20(6):1226-32. PubMed ID: 26123311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retroperitoneal and truncal sarcomas: prognosis depends upon type not location.
    Perez EA; Gutierrez JC; Moffat FL; Franceschi D; Livingstone AS; Spector SA; Levi JU; Sleeman D; Koniaris LG
    Ann Surg Oncol; 2007 Mar; 14(3):1114-22. PubMed ID: 17206483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of tumor size as staging variable in the revised International Federation of Gynecology and Obstetrics stage I leiomyosarcoma: a population-based study.
    Garg G; Shah JP; Liu JR; Bryant CS; Kumar S; Munkarah A; Morris RT
    Int J Gynecol Cancer; 2010 Oct; 20(7):1201-6. PubMed ID: 20940535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and tolerability of trabectedin in elderly patients with sarcoma: subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma.
    Jones RL; Demetri GD; Schuetze SM; Milhem M; Elias A; Van Tine BA; Hamm J; McCarthy S; Wang G; Parekh T; Knoblauch R; Hensley ML; Maki RG; Patel S; von Mehren M
    Ann Oncol; 2018 Sep; 29(9):1995-2002. PubMed ID: 30084934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multifactorial analysis of survival in primary extremity liposarcoma.
    Chang HR; Gaynor J; Tan C; Hajdu SI; Brennan MF
    World J Surg; 1990; 14(5):610-8. PubMed ID: 2238661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.